TARS
TARS
NASDAQ · Pharmaceuticals

Tarsus Pharmaceuticals Inc

Mid-Cap Stocks Pharmaceutical Stocks Healthcare Stocks
$64.51
-2.24 (-3.36%)
As of Mar 22, 9:59 PM ET ·
Analyst Consensus
Strong Buy
15
Analysts
High
Coverage
Buy 14 93%
Hold 1 7%
Sell 0 0%
Price Target
Analyst Price Target +26.4% upside
Low Target $66.63
Average Target $81.52
High Target $107.19
Current Price $64.51
Current
$64.51
Target
$81.52
$66.63 $81.52 avg $107.19
Scenario Analysis
Bear Case
$66.63
3.3%
Low target
Base Case
$81.52
+26.4%
Avg target
Bull Case
$107.19
+66.2%
High target
Risk/Reward
20.1x
Highly favorable
Price in Context
52-Week High
$85.25
-24.3% from high
52-Week Low
$38.51
+67.5% from low
50-Day SMA
$73.37
-12.1% vs SMA
200-Day SMA
$59.46
+8.5% vs SMA
RSI (14)
49.6
Neutral
Target vs 52W High
$81.52
-4.4% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
 Strong Buy 39 77% $1,330.33 +47.3%
JNJ
Johnson & Johnson
 Buy 32 59% $299.55 +27.3%
MRK
Merck & Co. Inc.
 Buy 36 67% $159.27 +36.9%
PFE
Pfizer Inc.
 Hold 35 40% $33.90 +25.7%
BMY
Bristol-Myers Squibb Co
 Hold 36 42% $174.50 +204.1%
ZTS
Zoetis Inc
 Buy 25 64% $209.87 +81.0%
RPRX
Royalty Pharma Plc- Cl A
 Strong Buy 16 88% $36.26 -20.4%
VTRS
Viatris Inc
 Buy 18 67% $122.82 +819.3%